Sientra appoints Philippe A. Schaison to board
Dr. Schaison has extensive experience leading global aesthetic organizations.
In November, 2016, Dr. Schaison joined Syneron Medical and currently serves as CEO of Syneron Candela North America and Global Executive Vice President Strategy and Business Development.
Previously, Dr. Schaison served as President of Allergan’s U.S. aesthetic and dermatology business.
Prior to joining Allergan, Dr. Schaison served as President, World Wide Travel Retail & Regional President, LATAM and MEA, at Clarins in New York.
Earlier, he served as CEO for Aesthetic Factors and as Vice President of Global Skin Care for Johnson & Johnson, with P&L responsibility for Aveeno, Clean & Clear, Lubriderm, and Ambi, and in executive positions at L'Oréal.
Dr. Schaison sits on the Board of the Galien Foundation and SENTÉ, Inc., a privately held specialty aesthetics company.
Dr. Schaison earned his MBA (Marketing) from the Hautes Etudes Commerciales (H.E.C.) in Paris, and a Doctorate in Pharmacy (Industrial) from the University of Paris. ■
LATEST MOVES FROM United Kingdom
- Town Centre Securities appoints Mark Dilley as finance director
- Plus500 promotes Penelope Judd to chairman
- IGas Energy appoints two to board
- EVR Holdings appoints Ian Hanson as director
- Morgan Sindall Group appoints Tracey Killen as director
More inside POST